Our Blog

Blog

How Research-Use Peptide Companies Can Protect Their Assets in a High-Scrutiny Environment

Blog

Legal Issues AI Technology Companies Must Address When Building and Scaling

Blog

Why Did Peptide Sciences Shut Down? What It May Mean for the Peptide Industry

Blog

Beyond the Sale: Alternative Lithotripsy Commercial Models That Can Reduce Stark Exposure

Blog

AI Data Privacy Obligations: What Businesses Need to Know in 2026

Blog

RFK Jr., Peptides, and the FDA: Why Social Media Is Overhyping the Legal Reality